Sep 5, 2023 | Alternative Reimbursement Strategies, Claims, Comparative Effectiveness, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, High-cost claims, Inflation, MedBen Rx, MedBen WellLiving, Reference-Based Pricing, Rx Costs, Savings, Self-funding, Specialty Care, Survey, Wellness
A new survey by International Foundation of Employee Benefit Plans found employers expect plan costs to increase seven percent in 2024. As to why, they gave a range of answers, with the top four reasons representing 71 percent of responses (see chart below). As it...
Aug 22, 2023 | Alternative Reimbursement Strategies, Appeals, Cost Savings, Fair Market Pricing, Savings
MedBen continues to offer alternative reimbursement strategies that offer the same access to quality care as PPOs, but with even greater savings. And our latest strategy has proven to reduce medical spend in a big way – saving employers, on average, nearly 70% on...
Aug 8, 2023 | Cancer, Chronic conditions, Claims, Cost Savings, Heart, High-cost claims, MedBen WellLiving, Savings, Stop-Loss
Cancer and heart disease account for 37% of total stop-loss claim reimbursements over the past four years. This demonstrates once again the importance of a wellness program to catch chronic conditions, and reduce the risk of high-cost claims, at their earliest stages....
Aug 7, 2023 | Access solutions, Case Studies, Cost Savings, Drug costs, Limited use HRA, MedBen Rx, Patient advocacy program, Pharmacy, Rx Costs, Savings, Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Jul 13, 2023 | Client Report, Cost Savings, Health care costs, Savings, Trend
Medical costs are expected to increase 7% in 2024, according to a new report from PricewaterhouseCoopers (PwC). This would match the largest single-year increase since the beginning of the pandemic. “The higher medical cost trend in 2024 reflects health plans’...
Jul 11, 2023 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Specialty Drugs, Transparency, Value
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
